2.93
price up icon1.03%   0.03
 
loading
Zura Bio Ltd stock is traded at $2.93, with a volume of 38,669. It is up +1.03% in the last 24 hours and down -39.34% over the past month. Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.
See More
Previous Close:
$2.90
Open:
$2.94
24h Volume:
38,669
Relative Volume:
0.09
Market Cap:
$197.85M
Revenue:
-
Net Income/Loss:
$-60.36M
P/E Ratio:
-0.6997
EPS:
-4.1875
Net Cash Flow:
$-15.05M
1W Performance:
-18.61%
1M Performance:
-39.34%
6M Performance:
-46.73%
1Y Performance:
-34.30%
1-Day Range:
Value
$2.905
$2.975
1-Week Range:
Value
$2.78
$3.7393
52-Week Range:
Value
$2.00
$6.35

Zura Bio Ltd Stock (ZURA) Company Profile

Name
Name
Zura Bio Ltd
Name
Phone
858-247-0520
Name
Address
4225 EXECUTIVE SQUARE, LA JOLLA
Name
Employee
15
Name
Twitter
Name
Next Earnings Date
2024-08-12
Name
Latest SEC Filings
Name
ZURA's Discussions on Twitter

Compare ZURA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
ZURA 2.92 197.85M 0 -60.36M -15.05M -4.1875
VRTX 445.32 115.74B 10.63B -479.80M -1.35B 13.33
REGN 736.78 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 584.00 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 247.00 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.17 24.49B 3.30B -501.07M 1.03B 11.54

Zura Bio Ltd Stock (ZURA) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-25-23 Initiated Oppenheimer Outperform
Jun-22-23 Initiated Guggenheim Buy
Jun-14-23 Initiated Chardan Capital Markets Buy
May-24-23 Initiated Raymond James Strong Buy

Zura Bio Ltd Stock (ZURA) Latest News

pulisher
Nov 15, 2024

GREAT POINT PARTNERS LLC Reduces Stake in Zura Bio Ltd - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

ADAR1 Capital Management, LLC Acquires New Stake in Zura Bio Ltd - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Zura Bio advances Phase 2 study for systemic sclerosis treatment - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis - Yahoo Finance

Nov 14, 2024
pulisher
Nov 09, 2024

Guggenheim maintains Buy on Zura Bio, target steady at $15 - Investing.com India

Nov 09, 2024
pulisher
Nov 08, 2024

Guggenheim maintains Buy on Zura Bio, target steady at $15 By Investing.com - Investing.com UK

Nov 08, 2024
pulisher
Nov 07, 2024

Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - BioSpace

Nov 07, 2024
pulisher
Nov 06, 2024

Zura Bio (NASDAQ:ZURA) Stock Rating Upgraded by Leerink Partnrs - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

Piper Sandler sets price target on Zura Bio shares, cites positive trial data - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Leerink Partners initiates Zura Bio stock with Outperform rating, $15 target - Investing.com

Nov 05, 2024
pulisher
Oct 30, 2024

Zura Bio Ltd re-elects board, ratifies auditor at AGM By Investing.com - Investing.com Australia

Oct 30, 2024
pulisher
Oct 30, 2024

Zura Bio to Participate in Two Upcoming Investor Conferences in November - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

Zura Bio Ltd re-elects board, ratifies auditor at AGM - Investing.com India

Oct 29, 2024
pulisher
Oct 18, 2024

Zura Bio announces departure of Chief Scientific Officer By Investing.com - Investing.com Australia

Oct 18, 2024
pulisher
Oct 18, 2024

Zura Bio announces departure of Chief Scientific Officer - Investing.com India

Oct 18, 2024
pulisher
Oct 17, 2024

Private equity firms among Zura Bio Limited's (NASDAQ:ZURA) largest shareholders, saw gain in holdings value after stock jumped 14% last week - Simply Wall St

Oct 17, 2024
pulisher
Oct 17, 2024

Bullish Zura Bio Insiders Loaded Up On US$1.01m Of Stock - Yahoo Finance

Oct 17, 2024
pulisher
Sep 29, 2024

Forefront Analytics LLC Has $145,000 Holdings in Zura Bio Limited (NASDAQ:ZURA) - Defense World

Sep 29, 2024
pulisher
Sep 25, 2024

Zura Bio Limited (NASDAQ:ZURA) Shares Sold by Affinity Asset Advisors LLC - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

Should investors be concerned about Zura Bio Ltd (ZURA)? - US Post News

Sep 24, 2024
pulisher
Sep 20, 2024

A stock that deserves closer examination: Zura Bio Ltd (ZURA) - US Post News

Sep 20, 2024
pulisher
Sep 20, 2024

Institutions profited after Zura Bio Limited's (NASDAQ:ZURA) market cap rose US$45m last week but private equity firms profited the most - Yahoo Finance

Sep 20, 2024
pulisher
Sep 20, 2024

Piper Sandler maintains Overweight rating on Zura Bio shares - Investing.com

Sep 20, 2024
pulisher
Sep 19, 2024

Zura Bio Ltd [ZURA] Director makes an insider sale of 3,800,000 shares worth 10,260,000. - Knox Daily

Sep 19, 2024
pulisher
Sep 19, 2024

Piper Sandler maintains Overweight rating on Zura Bio shares By Investing.com - Investing.com Australia

Sep 19, 2024
pulisher
Sep 19, 2024

Zura Bio Ltd (ZURA) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle

Sep 19, 2024
pulisher
Sep 18, 2024

Zura Bio (NASDAQ:ZURA) versus Aligos Therapeutics (NASDAQ:ALGS) Critical Comparison - Defense World

Sep 18, 2024
pulisher
Sep 11, 2024

A Guide To The Risks Of Investing In Zura Bio Ltd (ZURA) - Knox Daily

Sep 11, 2024
pulisher
Sep 09, 2024

Have Zura Bio Insiders Been Selling Stock? - Simply Wall St

Sep 09, 2024
pulisher
Sep 06, 2024

Zura Bio director Sidhu Someit sells shares worth over $200,000 - Investing.com

Sep 06, 2024
pulisher
Sep 05, 2024

Taking a look at what insiders are doing to gauge the Zura Bio Ltd (ZURA)’s direction - Knox Daily

Sep 05, 2024
pulisher
Sep 03, 2024

Zura Bio to Present at Three Upcoming Investor Conferences in September - Yahoo Finance

Sep 03, 2024
pulisher
Sep 02, 2024

Zura Bio Ltd [ZURA] Stock bought by Insider Ploos van Amstel Arnout for $0.5 million - Knox Daily

Sep 02, 2024
pulisher
Sep 02, 2024

Get in on Zura Bio Ltd’s (ZURA) buy-in window today! - SETE News

Sep 02, 2024
pulisher
Aug 27, 2024

Zura Bio Ltd (ZURA) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Aug 27, 2024
pulisher
Aug 21, 2024

Zura Bio issues warrants after share surrender - Investing.com India

Aug 21, 2024
pulisher
Aug 21, 2024

Zura Bio Ltd [ZURA] Investment Guide: What You Need to Know - Knox Daily

Aug 21, 2024
pulisher
Aug 17, 2024

Chardan Capital Comments on Zura Bio Limited’s FY2024 Earnings (NASDAQ:ZURA) - Defense World

Aug 17, 2024
pulisher
Aug 17, 2024

Cantor Fitzgerald Reiterates Overweight Rating for Zura Bio (NASDAQ:ZURA) - Defense World

Aug 17, 2024
pulisher
Aug 13, 2024

Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights - Lelezard

Aug 13, 2024
pulisher
Aug 13, 2024

Zura Bio Limited (NASDAQ:ZURA) Sees Significant Increase in Short Interest - Defense World

Aug 13, 2024
pulisher
Aug 12, 2024

Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants - Yahoo Finance

Aug 12, 2024
pulisher
Aug 12, 2024

Trading Day Triumph: Zura Bio Ltd (ZURA) Ends at 3.39, a -4.24 Surge/Plunge - The Dwinnex

Aug 12, 2024
pulisher
Aug 11, 2024

Zura Bio Limited (NASDAQ:ZURA) Given Consensus Rating of “Buy” by Analysts - Defense World

Aug 11, 2024
pulisher
Aug 09, 2024

Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants - Yahoo Finance

Aug 09, 2024
pulisher
Aug 08, 2024

Insider Buyers At Zura Bio Likely Disappointed With 11% Slide - Simply Wall St

Aug 08, 2024
pulisher
Aug 07, 2024

Investing in Zura Bio Ltd (ZURA): What You Must Know - Knox Daily

Aug 07, 2024
pulisher
Aug 04, 2024

Zura Bio Names Robert Lisicki As CEO & Director Of The Board - Contract Pharma

Aug 04, 2024
pulisher
Jul 31, 2024

Zura Bio Ltd (ZURA) rating initates by Piper Sandler - Knox Daily

Jul 31, 2024
pulisher
Jul 26, 2024

Zura Bio Limited (NASDAQ:ZURA) Short Interest Up 152.1% in July - Defense World

Jul 26, 2024
pulisher
Jul 25, 2024

Zura Bio Ltd reaches settlement with former CEO - Investing.com India

Jul 25, 2024

Zura Bio Ltd Stock (ZURA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):